In this section
Last Updated: 27 September 2017
Body System: Musculoskeletal system
Indications, dose adjustments and monitoring requirements for disease modifying drugs (DMDs) (licensed and unlicensed indications) included in this Framework are in line with national guidance published by the British Society for Rheumatology 2017.
St Helens and Knowsley Teaching Hospitals NHS Trust